Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Coagulation factor XI' and Ligand = 'BDBM285991'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Coagulation factor XI (Homo sapiens (Human))	BDBM285991 ((+/-)-Methyl N-{8-[(1-carbamimidoylpiperidin-4-yl)...) Show SMILES COC(=O)Nc1ccc2c(NC(=O)CCCCCC(NC2=O)C(=O)NC2CCN(CC2)C(N)=N)c1 Show InChI InChI=1S/C23H33N7O5/c1-35-23(34)27-15-7-8-16-18(13-15)28-19(31)6-4-2-3-5-17(29-20(16)32)21(33)26-14-9-11-30(12-10-14)22(24)25/h7-8,13-14,17H,2-6,9-12H2,1H3,(H3,24,25)(H,26,33)(H,27,34)(H,28,31)(H,29,32)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	1.50E+3	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The effectiveness of compounds of the present invention as inhibitors of the coagulation Factors XIa, VIIa, IXa, Xa, XIIa, plasma kallikrein or throm...				US Patent US10081623 (2018) BindingDB Entry DOI: 10.7270/Q24B33CM
					More data for this Ligand-Target Pair